Appointment booking for Dr. Valery Akopov, MD is currently not available.Dr. Valery Akopov, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Valery Akopov, MD (he/him) is a Internist in Atlanta, GA with over 18 years of experience. What is your opinion of Dr. Valery Akopov, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Valery Akopov, MD has received over $1,307 which includes payments from the following companies:
$341.57 from Janssen Pharmaceuticals, Inc
$230.78 from Pfizer Inc.
$144.37 from sanofi-aventis U.S. LLC
$77.86 from Valeant Pharmaceuticals North America LLC
$64.59 from GlaxoSmithKline, LLC.
$60.89 from Salix Pharmaceuticals, Ltd
$56.13 from Actavis Pharma Inc
$55.34 from Allergan Inc.
$52.02 from Merck Sharp & Dohme Corporation
$42.70 from E.R. Squibb & Sons, L.L.C.
$31.23 from FOREST PHARMACEUTICALS, INC.
$28.92 from Medtronic Sofamor Danek USA, Inc.
$24.26 from Astellas Pharma US Inc
$18.92 from Mallinckrodt LLC
$18.78 from Otsuka America Pharmaceutical, Inc.
$16.61 from Covidien Sales LLC
$15.25 from Cubist Pharmaceuticals Inc
$14.40 from Boehringer Ingelheim Pharmaceuticals, Inc.
$12.54 from KCI USA, Inc
Payments received by Dr. Valery Akopov, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!